Home/Filings/4/0001209191-22-038985
4//SEC Filing

TRENARY C RUSSELL III 4

Accession 0001209191-22-038985

CIK 0001649989other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 5:07 PM ET

Size

5.2 KB

Accession

0001209191-22-038985

Insider Transaction Report

Form 4
Period: 2022-06-21
TRENARY C RUSSELL III
DirectorCEO and President
Transactions
  • Purchase

    Common Stock

    2022-06-21$1.06/sh+19,925$21,12154,925 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.03 to $1.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Issuer

Outlook Therapeutics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1
  • filerCIK 0001227307

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:07 PM ET
Size
5.2 KB